Table 1.
Patient ID | Age | Sex | Brain volume (mm3) | RT volumes (mm3) |
Metabolic volumes (mm3) |
% of MTVCho outside of: |
% of MTVNAAoutside of: |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTV | Edema | CTV60 | CTV46 | MRSIQ | MTVCho | MTVNAA | GTV | Edema | CTV60 | CTV46 | GTV | Edema | ||||
T1* | 40 | M | 1341 | 24 | 151 | 280 | 415 | 989 | 27 | 150 | 99.8 | 50.9 | 0.3 | 0.0 | 83.8 | 20.6 |
T2 | 53 | M | 1242 | 70 | 101 | 352 | 359 | 872 | 10 | 28 | 39.6 | 29.8 | 0.1 | 0.1 | 0.7 | 0.1 |
T3 | 60 | F | 1297 | 31 | 44 | 187 | 157 | 922 | 37 | 31 | 51.0 | 39.7 | 0.0 | 0.0 | 22.8 | 14.2 |
T4 | 60 | M | 1335 | 116 | 207 | 505 | 566 | 941 | 15 | 124 | 25.6 | 6.4 | 0.0 | 0.0 | 18.3 | 5.1 |
T5 | 31 | F | 1122 | 20 | 31 | 188 | 176 | 798 | 20 | 18 | 84.2 | 76.5 | 21.9 | 23.2 | 20.2 | 7.0 |
T6† | 47 | M | 1398 | 118 | 118 | 429 | 367 | 1067 | 104 | 91 | 24.7 | 24.7 | 0.1 | 0.1 | 9.0 | 9.0 |
T7# | 30 | M | 1268 | 12 | 156 | 266 | 410 | 907 | 161 | 185 | 92.8 | 25.1 | 15.6 | 3.2 | 93.4 | 22.3 |
T8 | 34 | M | 1406 | 31 | 187 | 350 | 590 | 1040 | 227 | 83 | 86.7 | 33.3 | 15.7 | 1.4 | 65.1 | 14.3 |
T9 | 50 | M | 1377 | 24 | 52 | 312 | 276 | 1023 | 12 | 44 | 91.8 | 90.8 | 7.4 | 12.7 | 52.5 | 27.2 |
T10 | 62 | F | 1188 | 43 | 91 | 310 | 347 | 893 | 16 | 68 | 54.3 | 46.6 | 21.3 | 20.8 | 39.4 | 8.1 |
T11 | 38 | M | 1239 | 100 | 255 | 483 | 533 | 881 | 21 | 153 | 47.2 | 11.0 | 0.0 | 0.3 | 39.3 | 11.9 |
T12 | 47 | M | 1439 | 61 | 89 | 409 | 396 | 1072 | 17 | 67 | 97.8 | 95.5 | 55.8 | 8.8 | 25.2 | 11.5 |
T13 | 69 | M | 1322 | 59 | 163 | 371 | 451 | 978 | 2 | 72 | 100 | 100 | 100 | 86.5 | 30.5 | 2.1 |
T14 | 66 | M | 1284 | 42 | 82 | 466 | 443 | 943 | 58 | 32 | 46.2 | 24.4 | 0.7 | 3.4 | 23.5 | 8.0 |
T15§ | 41 | F | 1302 | 122 | 221 | 491 | 561 | 969 | 28 | 104 | 63.3 | 35.5 | 3.4 | 3.5 | 14.5 | 2.6 |
T16 | 38 | M | 1497 | 14 | 96 | 279 | 365 | 1133 | 3 | 8 | 45.2 | 0.0 | 0.0 | 0.0 | 66.8 | 14.4 |
T17 | 65 | F | 1079 | 75 | 96 | 280 | 296 | 768 | 35 | 33 | 64.3 | 57.3 | 10.4 | 17.0 | 9.9 | 6.1 |
T18 | 47 | M | 1564 | 161 | 222 | 589 | 551 | 1153 | 19 | 61 | 5.5 | 5.5 | 2.0 | 2.0 | 4.6 | 3.1 |
T19 | 50 | F | 1117 | 36 | 108 | 241 | 311 | 840 | 14 | 31 | 46.7 | 10.2 | 1.4 | 1.4 | 19.3 | 2.7 |
Median | 47 | - | 1302 | 43 | 108 | 350 | 396 | 943 | 20 | 67 | 54.3 | 33.3 | 2.0 | 2.0 | 22.8 | 8.1 |
IQR | 21 | - | 147 | 60 | 85 | 168 | 163 | 144.5 | 21.5 | 66 | 46.4 | 36.4 | 15.6 | 10.7 | 26.8 | 9.0 |
Abbreviations: Cho = choline; CTV46 = clinical target volume, receiving radiation dose of 46 Gy (CTV46 = edema + 2 cm); CTV60 = clinical target volume, receiving radiation dose of 60 Gy (CTV60 = GTV+2.5 cm); F = female; GTV = gross tumor volume; IQR = interquartile range (a measure of statistical dispersion, being equal to the difference between the upper [75th percentile] and lower [25th percentile] quartile); M = male; MRSI = magnetic resonance spectroscopic imaging; MRSIQ = volume of MRSI within the “quality mask”; MTV = metabolic tumor volume; MTVCho = MTV, based on Cho values above estimated threshold; MTVNAA = MTV, based on NAA values below estimated threshold; NAA = N-acetylaspartate; RT = radiation therapy.
Data from this patient are reviewed in detail in Figure 2.
Data from this patient are reviewed in detail in Figure 3.
Data from this patient are reviewed in detail in Figure 5.
Data from this patient are reviewed in detail in Figure 4.